409 related articles for article (PubMed ID: 16282380)
21. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
[TBL] [Abstract][Full Text] [Related]
22. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
[TBL] [Abstract][Full Text] [Related]
24. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
Verguet S; Stalcup M; Walsh JA
Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
[TBL] [Abstract][Full Text] [Related]
25. Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa.
Hutton G; Wyss K; N'Diékhor Y
Int J Health Plann Manage; 2003; 18(2):117-36. PubMed ID: 12841152
[TBL] [Abstract][Full Text] [Related]
26. HIV prevention cost-effectiveness: a systematic review.
Galárraga O; Colchero MA; Wamai RG; Bertozzi SM
BMC Public Health; 2009 Nov; 9 Suppl 1(Suppl 1):S5. PubMed ID: 19922689
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of screening and correcting refractive errors in school children in Africa, Asia, America and Europe.
Baltussen R; Naus J; Limburg H
Health Policy; 2009 Feb; 89(2):201-15. PubMed ID: 18621429
[TBL] [Abstract][Full Text] [Related]
28. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
29. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
[TBL] [Abstract][Full Text] [Related]
30. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency.
Dandona L; Sisodia P; Kumar SG; Ramesh YK; Kumar AA; Rao MC; Marseille E; Someshwar M; Marshall N; Kahn JG
BMC Public Health; 2005 Sep; 5():98. PubMed ID: 16181491
[TBL] [Abstract][Full Text] [Related]
31. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
Dowdy DW; Sweat MD; Holtgrave DR
AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.
Goodman CA; Mutemi WM; Baya EK; Willetts A; Marsh V
Health Policy Plan; 2006 Jul; 21(4):275-88. PubMed ID: 16682433
[TBL] [Abstract][Full Text] [Related]
35. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
Lo NC; Bogoch II; Blackburn BG; Raso G; N'Goran EK; Coulibaly JT; Becker SL; Abrams HB; Utzinger J; Andrews JR
Lancet Glob Health; 2015 Oct; 3(10):e629-38. PubMed ID: 26385302
[TBL] [Abstract][Full Text] [Related]
36. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study.
Kern E; Verguet S; Yuhas K; Odhiambo FH; Kahn JG; Walson J
Trop Med Int Health; 2013 Aug; 18(8):916-24. PubMed ID: 23659539
[TBL] [Abstract][Full Text] [Related]
37. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
Binagwaho A; Pegurri E; Muita J; Bertozzi S
PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
[TBL] [Abstract][Full Text] [Related]
38. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
Gopalappa C; Stover J; Shaffer N; Mahy M
AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
40. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
Quaife M; Terris-Prestholt F; Eakle R; Cabrera Escobar MA; Kilbourne-Brook M; Mvundura M; Meyer-Rath G; Delany-Moretlwe S; Vickerman P
J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29537654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
